N = 681(100%) | |
---|---|
Female gender n (%) | 511 (94.8) |
Age, mean (± SD) | 54 (± 14) |
Age at diagnosis, mean (± SD) | 50 (± 13) |
Follow up (years), mean (± SD) | 4.7 (± 4.9) |
Xeroftalmia n (%) | 618/659 (93.78) |
Xerostomia n (%) | 581/672 (86.46) |
Schirmer’s positive test n (%) | 454/499 (90.98) |
Decreased Unstimulated oral salivary flow n (%) | 213/258 (82.56) |
Rheumatoid Factor (RF) (+) n (%) | 303/589 (51.34) |
Anti Ro/SS-A (+) n (%) | 467/627 (74.48) |
Anti La/SS-B (+) n (%) | 262/608 (43.09) |
Positive biopsy n (%) | 345/400 (86.25) |
Salivary Gland Enlargement n (%) | 186 (27.31) |
Neuropathy n (%) | 67 (9.84) |
Arthralgia n (%) | 436 (64.02) |
Arthritis n (%) | 191 (28.05) |
Raynaud’s phenomenon n (%) | 101 (14.83) |